Results 91 to 100 of about 36,025 (301)

A 52‐week open‐label extension study to evaluate the safety and efficacy of oral rimegepant for the preventive treatment of migraine

Headache: The Journal of Head and Face Pain, EarlyView.
Abstract Objective To assess the safety, tolerability, and treatment effects of rimegepant 75 mg every other calendar day (EOD) for the preventive treatment of migraine in a 52‐week, open‐label extension (OLE) study. Background Rimegepant is an oral small molecule calcitonin gene–related peptide receptor antagonist approved for the acute treatment of ...
David Kudrow, Robert S. Croop, Alexandra Thiry, Richard B. Lipton   +3 more
wiley   +1 more source

A retrospective review of treatment patterns of antiemetic agents for chemotherapy-induced nausea and vomiting

SAGE Open Medicine, 2018
Objectives: To evaluate the treatment pattern of antiemetic agents used for chemotherapy-induced nausea and vomiting in a tertiary hospital in Saudi Arabia. Methods: Over a period of 7 weeks, all new chemotherapy order sheets were collected and evaluated
Abdulrahman Alamri, Yousef A Alawlah, Yanru Qiao, Junling Wang   +3 more
doaj   +1 more source

Acute emesis: moderately emetogenic chemotherapy [PDF]

, 2010
This paper is a review of the recommendations for the prophylaxis of acute emesis induced by moderately emetogenic chemotherapy as concluded at the third Perugia Consensus Conference, which took place in June 2009.
Bria, Emilio, Herrstedt, Jørn, Hesketh, Paul J, Rapoport, Bernardo, Rittenberg, Cynthia, Roila, Fausto, Warr, David   +6 more
core   +1 more source

Reduction of opioid and barbiturate use following initiation of rimegepant for migraine in the United States

Headache: The Journal of Head and Face Pain, EarlyView.
Abstract Objective The primary objective of this study was to evaluate opioid and barbiturate utilization before and after the first prescription of the calcitonin gene–related peptide receptor antagonist rimegepant in individuals with migraine. Background Although not recommended in migraine treatment guidelines, opioids and barbiturates are often ...
Noah Rosen, Aaron Jenkins, Karin Hygge Blakeman, Feng Dai, Lucy Abraham, Chelsea Leroue, Josh Brown   +6 more
wiley   +1 more source

Adequate antiemetic treatment in patients receiving antitumor drug therapy

Опухоли головы и шеи
Despite the widespread use of immuno-oncological and targeted therapy in the treatment of malignant tumors, in real clinical practice the role of chemotherapy is still significant, used both in mono regimen and in combination with other antitumor drugs ...
M. B. Pak, P.  A. Zeynalova, A. M. Mudunov, S. V. Berelavichus, F.  U. Tankieva, I. A. Duguzheva   +5 more
doaj   +1 more source

Study participant impression of use and satisfaction with STS101 (dihydroergotamine nasal powder): Results from the open‐label ASCEND acute migraine study

Headache: The Journal of Head and Face Pain, EarlyView.
Abstract Objective/Background This study was undertaken to assess participants' impression of use and satisfaction with STS101 in a long‐term, open‐label safety study. The ASCEND study assessed the safety and tolerability of STS101, an investigational drug–device combination of 5.2 mg dihydroergotamine in a single‐use nasal delivery device for the ...
Jessica Ailani, Larry Charleston IV, Shannon Strom, Detlef Albrecht, Robert Cowan   +4 more
wiley   +1 more source

Olanzapine –The cost-effective anti-emetic

Journal of Dr. NTR University of Health Sciences
Introduction: Chemotherapy induced nausea and vomiting can be distressing when not adequately controlled. Many agents are used prophylactically to prevent CINV (Chemotherapy induced nausea and vomiting).
R Ramesh Reddy, Ravi Chandran Ambalathandi, Haneesha Polavarapu, Manickavasagam Meenakshisundaram   +3 more
doaj   +1 more source

Development, characterization, in vitro and ex vivo evaluation of antiemetic transdermal patches of ondansetron hydrochloride and dexamethasone [PDF]

, 2021
K. C. Sahu, Saman Pathan, Kapil Khatri, Neeraj Upmanyu, Satish Shilpi   +4 more
openalex   +1 more source

The Discovery, Use and Impact of Platinum Salts as Chemotherapy Agents for Cancer [PDF]

, 2007
Annotated and edited transcript of a Witness Seminar held on 4 April 2006. Introduction by Professor Matti Aapro, Grenolier, Switzerland.First published by the Wellcome Trust Centre for the History of Medicine at UCL, 2007.©The Trustee of the Wellcome ...
Christie, DA, Tansey, EM
core  

Vaporized cannabis versus placebo for acute migraine: A randomized, double‐blind, placebo‐controlled crossover trial

Headache: The Journal of Head and Face Pain, EarlyView.
Abstract Objective To assess the efficacy of cannabis for the treatment of acute migraine. Background Preclinical and retrospective studies suggest cannabinoids may be effective in migraine treatment. However, there have been no randomized clinical trials examining the efficacy of cannabinoids for acute migraine.
Nathaniel M. Schuster, Mark S. Wallace, Thomas D. Marcotte, Dawn C. Buse, Euyhyun Lee, Lin Liu, Michelle Sexton   +6 more
wiley   +1 more source